| # | Title | Journal | Year | Citations |
|---|
| 1 | Heterotopic Ossification: A Comprehensive Review | JBMR Plus | 2019 | 277 |
| 2 | Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory | JBMR Plus | 2021 | 158 |
| 3 | Bone Health After Bariatric Surgery | JBMR Plus | 2018 | 125 |
| 4 | Controversies in Vitamin D: A Statement From the Third International Conference | JBMR Plus | 2020 | 118 |
| 5 | Discogenic Back Pain: Literature Review of Definition, Diagnosis, and Treatment | JBMR Plus | 2019 | 114 |
| 6 | Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States | JBMR Plus | 2019 | 97 |
| 7 | Crosstalk Between MLO‐Y4 Osteocytes and C2C12 Muscle Cells Is Mediated by the Wnt/β‐Catenin Pathway | JBMR Plus | 2017 | 83 |
| 8 | Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research | JBMR Plus | 2019 | 79 |
| 9 | Bone Aging, Cellular Senescence, and Osteoporosis | JBMR Plus | 2021 | 65 |
| 10 | Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy | JBMR Plus | 2018 | 58 |
| 11 | Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review | JBMR Plus | 2018 | 58 |
| 12 | A Novel Distal Enhancer Mediates Inflammation‐, PTH‐, and Early Onset Murine Kidney Disease‐Induced Expression of the Mouse Fgf23 Gene | JBMR Plus | 2018 | 52 |
| 13 | The Gut Microbiome Is Altered in Postmenopausal Women With Osteoporosis and Osteopenia | JBMR Plus | 2021 | 48 |
| 14 | Cx43 Overexpression in Osteocytes Prevents Osteocyte Apoptosis and Preserves Cortical Bone Quality in Aging Mice | JBMR Plus | 2018 | 46 |
| 15 | New Insights Into Osteoclast Biology | JBMR Plus | 2021 | 45 |
| 16 | Vitamin D: Bolus Is Bogus—A Narrative Review | JBMR Plus | 2021 | 45 |
| 17 | Bone as a Preferential Site for Metastasis | JBMR Plus | 2019 | 44 |
| 18 | How To Build a Bone: PHOSPHO1, Biomineralization, and Beyond | JBMR Plus | 2019 | 44 |
| 19 | Primary Osteoporosis in Young Adults: Genetic Basis and Identification of Novel Variants in Causal Genes | JBMR Plus | 2018 | 43 |
| 20 | The Free Hormone Hypothesis: When, Why, and How to Measure the Free Hormone Levels to Assess Vitamin D, Thyroid, Sex Hormone, and Cortisol Status | JBMR Plus | 2021 | 43 |
| 21 | Vitamin D: Brain and Behavior | JBMR Plus | 2021 | 42 |
| 22 | Parathyroid Hormone Signaling in Osteocytes | JBMR Plus | 2018 | 41 |
| 23 | Obesity Represses CYP2R1, the Vitamin D 25‐Hydroxylase, in the Liver and Extrahepatic Tissues | JBMR Plus | 2020 | 39 |
| 24 | MicroRNA and Human Bone Health | JBMR Plus | 2019 | 38 |
| 25 | The Emerging Role of Osteocytes in Cancer in Bone | JBMR Plus | 2019 | 38 |
| 26 | Age‐Related Deterioration of Bone Toughness Is Related to Diminishing Amount of Matrix Glycosaminoglycans (GAGs) | JBMR Plus | 2018 | 37 |
| 27 | Rethinking Bone Disease in Kidney Disease | JBMR Plus | 2018 | 36 |
| 28 | PDGF Modulates BMP2‐Induced Osteogenesis in Periosteal Progenitor Cells | JBMR Plus | 2019 | 36 |
| 29 | EGFR Signaling: Friend or Foe for Cartilage? | JBMR Plus | 2019 | 36 |
| 30 | Comparative Characterization of Osteoclasts Derived From Murine Bone Marrow Macrophages and RAW 264.7 Cells Using Quantitative Proteomics | JBMR Plus | 2018 | 35 |
| 31 | Fracture Risk in Dialysis and Kidney Transplanted Patients: A Systematic Review | JBMR Plus | 2019 | 35 |
| 32 | A Novel Fracture Prediction Model Using Machine Learning in a Community‐Based Cohort | JBMR Plus | 2020 | 35 |
| 33 | FGF23, Hypophosphatemia, and Emerging Treatments | JBMR Plus | 2019 | 34 |
| 34 | Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study | JBMR Plus | 2020 | 33 |
| 35 | Trends in Hip Fracture Incidence in Japan: Estimates Based on Nationwide Hip Fracture Surveys From 1992 to 2017 | JBMR Plus | 2021 | 32 |
| 36 | Osteomalacia and Vitamin D Status: A Clinical Update 2020 | JBMR Plus | 2021 | 32 |
| 37 | Trends in Vitamin D Status Around the World | JBMR Plus | 2021 | 31 |
| 38 | Fracture Healing in Two Adult Patients With Hypophosphatasia After Asfotase Alfa Therapy | JBMR Plus | 2018 | 30 |
| 39 | Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study | JBMR Plus | 2021 | 30 |
| 40 | The Hidden Burden of Fractures in People Living With HIV | JBMR Plus | 2018 | 29 |
| 41 | The Osteocyte Transcriptome Is Extensively Dysregulated in Mouse Models of Osteogenesis Imperfecta | JBMR Plus | 2019 | 29 |
| 42 | Recombinant Human Bone Morphogenetic Protein 6 Delivered Within Autologous Blood Coagulum Restores Critical Size Segmental Defects of Ulna in Rabbits | JBMR Plus | 2019 | 29 |
| 43 | Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities | JBMR Plus | 2019 | 29 |
| 44 | Mineral and Electrolyte Disorders With SGLT2i Therapy | JBMR Plus | 2019 | 28 |
| 45 | The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study | JBMR Plus | 2019 | 28 |
| 46 | Multiple Myeloma and Fatty Acid Metabolism | JBMR Plus | 2019 | 28 |
| 47 | Vitamin D and Clinical Cancer Outcomes: A Review of Meta‐Analyses | JBMR Plus | 2021 | 28 |
| 48 | Physical Determinants of Vitamin D Photosynthesis: A Review | JBMR Plus | 2021 | 28 |
| 49 | Effect of Denosumab on Femoral Periprosthetic BMD and Early Femoral Stem Subsidence in Postmenopausal Women Undergoing Cementless Total Hip Arthroplasty | JBMR Plus | 2019 | 27 |
| 50 | Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva‐Derived Endothelial Cells | JBMR Plus | 2019 | 26 |
